A

Accelerate Diagnostics
D

AXDX

1.65000
USD
-0.04
(-2.37%)
Market Closed
Volume
663
EPS
0
Div Yield
-
P/E
-1
Market Cap
41,322,306
OverviewSignalsIdeasNews
Related Instruments
    A
    ABMD
    0
    (0%)
    0.000000 USD
    BDX
    BDX
    -2.040
    (-0.90%)
    225.190 USD
    C
    COO
    -0.230
    (-0.23%)
    99.640 USD
    DHR
    DHR
    -8.985
    (-3.75%)
    235.83 USD
    EW
    EW
    1.620
    (2.45%)
    67.780 USD
    H
    HOLX
    1.040
    (1.34%)
    78.600 USD
    I
    ILMN
    -7.180
    (-5.05%)
    135.110 USD
    ISRG
    ISRG
    -10.30
    (-1.92%)
    547.83 USD
    MDT
    MDT
    1.520
    (1.77%)
    86.2 USD
    P
    PODD
    -0.83
    (-0.32%)
    260.18 USD
    RMD
    RMD
    3.500
    (1.51%)
    234.840 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    513.04 USD
    More
News

Title: Accelerate Diagnostics

Sector: Healthcare
Industry: Medical Devices
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.